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Endoplasmic reticulum stress responseCongenital pancreatic triglyceride lipase (PNLIP) deﬁciency is a rare disorder with uncertain genetic background
as most cases were described before gene sequencing was readily available. Recently, two brothers with PNLIP
deﬁciency were found to carry a homozygous missense mutation, c.662C N T (p.T221M) in the PNLIP gene
(J. Lipid Res. 2014. 55:307–312). Molecular modeling suggested the substitution would change the orientation
of residues in the catalytic site and disrupt the function of p.T221M PNLIP. To test the effect of the p.T221M
mutation on PNLIP function, we expressed wild-type and p.T221M PNLIP in human embryonic kidney (HEK)
293A cells and dexamethasone-differentiated AR42J rat acinar cells. In both cellular models, wild-type PNLIP
was secreted into the conditioned medium where it was readily detectable by protein staining, immunoblot or
lipase activity assays. In contrast, mutant p.T221M was not secreted into the medium, but it was present in cell
lysates where it accumulated in the insoluble fraction. Intracellular retention of mutant p.T221M resulted in
endoplasmic reticulum (ER) stress asmeasured by elevated XBP1 splicing and increased levels of ER chaperones.
Our results demonstrate that the presence of methionine at position 221 in the PNLIP protein sequence causes
misfolding and aggregation of the p.T221M mutant inside the cell. The consequent loss of enzyme secretion
adequately explains the clinical phenotype of PNLIP deﬁciency reported for homozygous carriers of p.T221M.
Furthermore, the ability of mutant p.T221M to induce ER stress suggests that this form of PNLIP deﬁciency
might cause acinar cell damage as well.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Although congenital pancreatic triglyceride lipase (PNLIP) deﬁcien-
cy is discussed in most textbooks of pediatric gastroenterology, there
are only a few reports of patients with evidence of this rare disorder
[1–10]. In each case, the PNLIP deﬁciency was demonstrated by enzy-
matic assay of pancreatic secretions. In no case, was a mutation in the
protein or gene reported. A recent effort to identify mutations in the
PNLIP gene of four patientswith absent lipase activity in their pancreatic
ﬂuid failed to ﬁnd any nonsense or missense mutations that could
explain the deﬁciency [11]. Thus, it has never been clear if the absence
of PNLIP activity in the pancreatic secretion of the reported patients, endoplasmic reticulum;GRP94,
e 1; PNLIP, pancreatic triglycer-
P1, X -box b in din g protei n-1
ttsburgh of UPMC, Division of
4401 Penn Ave, Pittsburgh, PAresulted from a gene mutation or another reason such as the presence
of a lipase inhibitor or technical problems with the sample collection
or with the lipase assay.
Recently, Behar et al. reported two brothers from a consanguineous
marriagewhohad clinical PNLIP deﬁciencywith steatorrhea and a novel
homozygous missense mutation in the PNLIP gene [12]. The heterozy-
gous carrier parents were clinically unaffected. A single base substitu-
tion in exon 6 (c.662C N T) changed the amino acid at position 221
(p.T221M). Thr221 is conserved in all known PNLIP sequences. It is lo-
cated in the β9 loop, which contributes to the active site of PNLIP [13].
In the crystal structure of human PNLIP, Thr221 forms a hydrogen
bond with Asp193, a residue in the Ser-His-Asp catalytic triad [14,15].
Molecular modeling suggests the substitution of Thr221 with the larger
amino acid, methionine, destabilizes the active site of PNLIP [12]. The
authors speculated that the brothers' steatorrhea resulted from de-
creased activity of p.T221M PNLIP.
To test the hypothesis that the p.T221Mmutation alters PNLIP func-
tion, we expressed Thr221 PNLIP and Met221 PNLIP in HEK 293A and
AR42J cells. We then determined the effect of the p.T221M mutation
on PNLIP expression, secretion and activity. Our results demonstrate
that the presence of methionine at position 221 in the protein sequence
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in the cell, is inactive and is not secreted into the medium.
2. Materials and methods
2.1. Nomenclature
Nucleotide numbering reﬂects codingDNAnumberingwith+1 cor-
responding to the A of the ATG translation initiation codon in PNLIP.
Amino acid residues are numbered starting with the initiator methio-
nine of the primary translation product for human PNLIP.
2.2. Expression plasmids, mutagenesis and adenovirus
The cDNA encoding human PNLIP was ampliﬁed by PCR using our
previously obtained full length human PNLIP cDNA clone as template
and subsequently subcloned into themammalian protein expression vec-
tor pcDNA3 (Invitrogen, Carlsbad, CA) [16]. The c.662C N T (p.T221M)
mutation was introduced by overlap extension PCR. The sequence of all
plasmid DNA constructs was veriﬁed by dideoxynucleotide sequencing.
Recombinant adenovirus carrying a His-tagged form of wild-type PNLIP
or mutant p.T221M was generated by Viraquest, Inc. (North Liberty, IA).
Control adenovirus was purchased from Viraquest.
2.3. Culture and transfection of mammalian cells
HEK 293A cells were purchased from ATCC (Manassas, VA) and
maintained in DMEM supplemented with 10% fetal bovine serum,
100 units/ml penicillin and 100 μg/ml streptomycin (#15140-122
GIBCO, Life Technologies, Grand Island, NY) at 37 °C in a 5% CO2-
humidiﬁed incubator. Sixteen hours prior to transfection, cells (2 ml/
well for 6-well plates and 10 ml/dish for 10-cm culture dishes) were
seeded at 75% conﬂuence. Transfections were carried out using FuGENE
6 (Roche Diagnostics, Indianapolis, IN). Brieﬂy, in 100 μl of Opti-MEM I
reduced serum medium (Invitrogen), 5 μl of FuGENE 6 was mixed
with 1.65 μg of plasmid DNA (pcDNA3, pcDNA3/PNLIP, or pcDNA3/
PNLIP p.T221M). The mixture was then added to the cells in each well
of 6-well plates. For RNA extraction, a mixture of 25 μl of FuGENE 6
and 10 μg of each plasmid DNA in 500 μl of Opti-MEM I reduced
serummedium was added for each 10-cm dish.
AR42J rat pancreatic acinar cells (ATCC #CRL-1492) were main-
tained in DMEM supplementedwith 20% fetal bovine serum, 4mMglu-
tamine and 100 units/ml penicillin and 100 μg/ml streptomycin at 37°C.
Prior to transfection, cells were plated in 6-well plates at a density of 106
cells per well and were grown in the presence of 100 nM dexametha-
sone for 48 h. Transduction with adenovirus were performed in 1 ml
OptiMEM containing 100 nM dexamethasone using the indicated viral
concentrations.
2.4. Collection of culture media and cells
Seventy-two hours after transfection, conditioned media from HEK
293A cellswerewithdrawnand subjected to 200 g×5min centrifugation
to obtain cell free conditioned media. Cells were washed twice gently
with ice-cold PBS and washed off the plates in 1.5 ml of PBS and centri-
fuged at 200 g × 5 min. For whole cell lysates, the resultant cell pellets
were resuspended in 300 μl of 1 × Laemmli buffer, followed by 3 × 15 s
sonication. Otherwise, cells were resuspended in 300 μl of RIPA buffer
(150 mM NaCl, 1.0% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS,
and 50 mM Tris, pH 8.0) supplemented with protease and phosphatase
inhibitors and incubated on ice for 10min, followed by 3 × 5 s sonication.
The cell lysates were clariﬁed by centrifugation at 16,000 g × 20 min at
4 °C, and the supernatants were designated as soluble lysate fraction.
The pellets were washed twice with ice-cold PBS and followed by
16,000 g × 5 min. The ﬁnal pellets were resuspended in 100 μl of1 × Laemmli buffer and sonicated until no particle was visible. This part
was designated as insoluble lysate fraction.
Conditionedmedia fromAR42J cells were harvested 24 h after trans-
duction. Cells were washed twicewith PBS, scraped from the tissue cul-
ture plates in 1 ml PBS and centrifuged for 10 min at 850 g. Cells were
resuspended in 200 μl Reporter Lysis Buffer (Promega, Madison, WI)
and 2 μl Halt Protease and Phosphatase Inhibitor Single-Use Cocktail
(#78442, Pierce — Thermo Scientiﬁc, Rockford, IL) was added. Cells
were incubated on ice for 15min and the lysatewas cleared by centrifu-
gation for 10 min at 16,000 g. For all cell lysate samples, the protein
concentration was measured with the Micro BCA Protein Assay Kit
(Pierce — Thermo Scientiﬁc).
2.5. Measurement of PNLIP protein secretion from AR42J cells
Proteins in the conditionedmedia (40 μl fromAR42J cells)were pre-
cipitatedwith 10% trichloroacetic acid (ﬁnal concentration), resuspend-
ed in 20 μl Laemmli sample buffer containing 100 mM dithiothreitol,
heat-denatured at 95 °C for 5 min and electrophoresed on 15% SDS-
polyacrylamide gels. Gels were stained with Coomassie Blue.
2.6. Lipase activity assay
Lipase activity of human PNLIPwas determined at 25 °C by using the
standard 5-min pH-stat method with the emulsion of tributyrin (114
mM) in a total volume of 15 ml. The reactions were carried out in the
presence or absence of over 5-fold molar excess of colipase at 4 mM so-
dium taurodeoxycholate (NaTDC) concentration. Fifty microliters of
conditioned medium from HEK 293A cells or 100 μl of conditioned me-
dium from AR42J cells were added to the reaction. For the assay of the
soluble cell lysate from HEK 293A cells, 100 μl (total volume of 300 μl)
was added to the reaction. Lipase activities are expressed as μmols of
fatty acid released per min.
2.7. Protein immunoblot
Conditionedmedia and cell lysates fromHEK 293A cells were treated
with 2 × Laemmli sample buffer supplemented with 2-mercaptoethanol.
After being heated to 95 °C for 5 min, the prepared conditioned medium
(20 μl) and cell lysate samples (10–30 μg forwhole cell lysate and soluble
fraction and 5–10 μg for insoluble fraction)were resolved on 4–15%Mini-
Protean TGX gels (Bio-Rad, Hercules, CA) and transferred onto an
Immobilon-Pmembrane (Millipore, Bedford,MA). For AR42J cells, condi-
tionedmedia (0.1 μl) and cell lysates (0.25 μg total protein for His-tag de-
tection, 2.5 μg total protein for α-tubulin detection or 5 μg total protein
for PNLIP detection) were treated as above and electrophoresed on 15%
Tris-glycine minigels and transferred onto an Immobilon-P membrane.
After blocking with 5% non-fat milk in PBS supplemented with 0.1%
Tween 20, the membrane was incubated with primary antibody at 4° C
overnight and thenwith secondary antibody for 1 h at room temperature.
The bands were detected using the SuperSignal West Femto Maximum
Sensitivity Substrate or the SuperSignal West Pico Chemiluminescent
Substrate (Pierce — Thermo Scientiﬁc, Rockford, IL).
Antibodies used in this study were as following: rabbit polyclonal an-
tibody against human PNLIP (1:5,000) was produced in our laboratory
[17]; rabbit anti-BiP (3177; 1:1,000), GRP94 (2104; 1:1,000), calnexin
(2679; 1:2,000), calreticulin (12238; 1:2,000), and rabbit anti-β tubulin
(2128; 1:5,000) and GAPDH (5174; 1:5,000) were purchased from Cell
Signaling (Danvers, MA); mouse monoclonal anti-α tubulin antibody
(T5168; 1:2,000) was from Sigma-Aldrich (St. Louis, MO), HRP-
conjugated goat polyclonal anti-mouse IgG (ab6798; 1:2,500) was from
Abcam (Cambridge, MA) and horse-radish peroxidase (HRP)-conjugated
mouse monoclonal penta-His antibody (34460; 1:2,000) was purchased
from Qiagen (Louisville, KY). The goat anti-rabbit IgG conjugated with
horseradish peroxidase (31460; 1:50,000) was purchased from Pierce —
Thermo Scientiﬁc.
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Total RNA was isolated from HEK 293A cells transfected with given
plasmid DNAs using TRIzol (Invitrogen), and 1.5 μg of RNA was then
reverse-transcribed with Moloney murine leukemia virus reverse tran-
scription kit fromAmbion (Austin, TX) at 44 °C for 1 h in a 20-μl reaction
volume. Semiquantitativemeasurements were performed by PCR of the
X-box binding protein-1 (XBP1) cDNA and its spliced form, using the
following primers that amplify both forms as follows: XBP1 forward
primer, 5′-CCT TGT AGT TGA GAA CCA GG-3′, and XBP1 reverse primer,
5′-GGGCTTGGT ATA TAT GTGG-3′. The XBP1 primers amplify 441- and
415-bp amplicons from the unspliced and spliced cDNAs, respectively.
As an endogenous control, a 261-bp fragment of GAPDHwas also ampli-
ﬁed, using the following primers: GAPDH sense primer, 5′-GTC CAC TGG
CGT CTT CAC CA-3′, and GAPDH antisense primer, 5′-GTGGCAGTG ATG
GCA TGG AC-3′. PCR products were run on 2% agarose gels, and the
bands were visualized by ethidium bromide staining.
Total RNA was extracted from AR42J cell lysates using the RNeasy
Plus Mini kit (Qiagen). RNA was reverse-transcribed using High Capac-
ity cDNA Reverse Transcription Kit (Applied Biosystems, Grand Island,
NY). XBP1 splicing was studied by PCR using a primer set forward: 5′-
GCT TGT GAT TGA GAA CCA GG-3′, reverse: 5′-AGG CTT GGT GTA TAC
ATG G-3′ that ﬂanked the spliced region and ampliﬁed both spliced
(421 bp) and unspliced (447 bp) forms. The PCR productswere resolved
on 2% agarose gels and stained with ethidium bromide. Expression of
mRNA for BiP and calreticulin was measured by real time PCR (7500
Real Time PCR System, Applied Biosystems) using TaqMan primers
with TaqMan Universal PCR Mastermix (Applied Biosystems). Gene ex-
pressionwas quantitated using the comparative CTmethod (ΔΔCTmeth-
od). Threshold cycle (CT) values were determinedwith the 7500 System
Sequence Detection Software 1.3. Expression levels of target genes were
ﬁrst normalized to the GAPDH internal control gene (ΔCT) and then to
expression levels measured in cells infected with 2 × 107 pfu/ml control
(vector only) adenovirus (ΔΔCT). Resultswere expressed as fold changes
calculated with the formula 2−ΔΔCT.
3. Results
3.1. Secretion and folding of p.T221M PNLIP
To determine if the p.T221M substitution affects the folding or func-
tion of PNLIP, we ﬁrst transfected HEK 293A cells with empty vector,
vector containing PNLIP or vector containing p.T221M PNLIP. These
cells are relatively easy to culture and can be reproducibly transfectedFig. 1. Secretion of PNLIP and p.T221M PNLIP from transfected HEK 293A cells. The media fr
tributyrin in 50 μl of mediumwasmeasured in the standard 5 minute pH-stat assay. Themean
by SDS PAGE and protein immunoblot with the rabbit anti-human PNLIP antisera followed by d
lipase in the samples were determined by densitometry of 3 separate experiments.with plasmids at high efﬁciency. Additionally, they have been used to
study secretion of a large variety of proteins and represent a good
model to study protein secretion. When we assayed conditioned medi-
um from the transfected cells for lipase activity, only the cells
transfected with PNLIP had detectable activity (Fig. 1A). The medium
fromcells transfected p.T221MPNLIP had no lipase activity.Wenext de-
termined if inactive p.T221M PNLIPwas present in the conditionedme-
dium by immunoblot analysis with our rabbit anti-human PNLIP
antibody (Fig. 1B and C). Whereas PNLIP was detectable in conditioned
medium, p.T221M PNLIP was undetectable suggesting the mutant
lipase was either poorly expressed in HEK 293T cells or not secreted
by these cells.
To help distinguish between these possibilities, we next determined
if p.T221M PNLIP was present inside the transfected cells. Protein im-
munoblot analysis of the whole cell lysate revealed the presence of
both PNLIP and p.T221M PNLIP in the cells (Fig. 2A). The amount of
themutant lipasewas signiﬁcantly higher (P≤ 0.001).We then separat-
ed the intracellular lipase into a soluble and detergent-insoluble fraction
by detergent extraction and centrifugation. Both lipaseswere present in
the soluble fraction (Fig. 2B). The amount of soluble p.T221MPNLIPwas
signiﬁcantly higher than the amount of PNLIP (P≤ 0.001). Lipase assay
100 μl of the PNLIP soluble intracellular fraction using tributyrin as sub-
strate revealed an activity of 1.8 ± 0.097 μmol fatty acid released per
min and no detectable activity in extracts from mock transfected or
p.T221M PNLIP (n= 3) suggesting the soluble p.T221Mwas in an inac-
tive conformation. Importantly, the amount of p.T221MPNLIP in the in-
soluble fraction was about 7-fold higher than the amount of PNLIP
(P≤ 0.001) (Fig. 2C). In both the soluble fraction and the insoluble frac-
tions we detected higher molecular weight antibody positive proteins
migrating above 100 kDa in the p.T221M samples. The bands were not
present in the PNLIP samples suggesting they did not result from non-
speciﬁc binding of the antibodies. The nature of these bands was not
further investigated.
We repeated these experiments in a rat acinar cell line, AR42J, trans-
duced with recombinant adenovirus. The amount of PNLIP in the medi-
um of transduced AR42J cells increased with increasing amounts of
adenovirus as determined by lipase assay, by SDS-PAGE and protein
staining and by protein immunoblot (Fig. 3A). As found in the HEK
293A cells, lipase activity was present in the conditioned medium from
cells transduced with PNLIP adenovirus but not in cells transduced with
p.T221M PNLIP adenovirus. Similarly, PNLIP protein was only detected
in the conditionedmedium from cells transducedwith PNLIP adenovirus
by protein staining or immunoblot. p.T221M PNLIP was not detected in
conditioned medium by either protein staining or immunoblot.om transfected cells was sampled 72 h after transfection. (A) The lipase activity against
and SD of 3 separate determinations is plotted. (B) The presence of PNLIP was determined
etectionwith the HRP conjugated goat anti-rabbit IgG antisera. (C) The relative amounts of
Fig. 2. The intracellular accumulation of PNLIP and p.T221M PNLIP in transfected HEK 293A cells. Seventy-two hours after transfection the cells were harvested and processed for total,
soluble and insoluble fractions as described in Materials and methods. The presence of PNLIP was determined by SDS PAGE and protein immunoblot with the rabbit anti-human PNLIP
antisera followed by detection with the HRP conjugated goat anti-rabbit IgG antisera. The relative amounts of lipase in the samples were determined by densitometry. The mean and
SDof 3 separate determinations are plotted. (A) The total amount of PNLIP and p.T221MPNLIP are shown.GAPDH serves as the loading control. (B) The amount of each lipase in the soluble
intracellular fraction is shown. (C) The amount of each lipase in the insoluble intracellular fraction is shown. ***P ≤ 0.001.
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p.T221M PNLIP in the cells as seen in the HEK 293A cells (Fig. 3B). The
amount of PNLIP and p.T221M PNLIP in the cells varied proportionatelyFig. 3. Expression of PNLIP and p.T221M PNLIP in adenovirus transduced AR42J cells. The cells w
diumwere assayed by SDS PAGE followed by Coomassie Blue staining (upper panel) or by prot
panel) orwere assayed for lipase activity against tributyrin in 100 μl ofmedium in the standard
plotted. (B) Aliquots of total cell lysate were analyzed by SDS PAGE and protein immunoblot w
loading control. (C) AR42J cells were transfected with 108 pfu adenovirus and the total, solublewith increasing viral titers. The amount of intracellular lipase was
higher in the cells transduced with p.T221M PNLIP. The intracellular re-
combinant lipases were separated into a soluble and an insolubleere transduced with three different titers of adenovirus. (A) Aliquots of conditioned me-
ein immunoblot with the HRP-conjugated mouse monoclonal penta-His antibody (middle
5minute pH-stat assay (bottompanel). Themean and SD of 3 separate determinations are
ith the HRP-conjugated mouse monoclonal penta-His antibody. α-Tubulin was used as a
and insoluble fractions were analyzed by protein immunoblot. ***P ≤ 0.001.
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both PNLIP and p.T221M PNLIP were present in the soluble fraction or
supernatant. Only a minor portion of PNLIP appeared in the insoluble
fraction. In contrast, a signiﬁcant fraction of the intracellular p.T221M
PNLIP was in the insoluble fraction.
3.2. Activation of the ER stress response
The accumulation of intracellular proteins in the detergent-insoluble
fraction suggests the protein hasmisfolded and formed insoluble aggre-
gates. If this is the case, an ER stress responsewill be activated. To deter-
mine if p.T221M PNLIP activates the UPR and ER stress response, we
measured the protein levels of several major ER chaperones, BiP,
calreticulin and GRP94 and the splicing of the mRNA encoding XBP1
in transfected HEK 293A cells. Overexpression of PNLIP and p.T221M
PNLIP resulted in upregulation of BiP protein levels compared to the
vector control (P ≤ 0.01) (Fig. 4A). Furthermore, levels of BiP in the
cells transfected with p.T221M PNLIP were signiﬁcantly higher than
the BiP levels in cells transfected with PNLIP (P ≤ 0.01). The levels of
calreticulin were elevated above controls in HEK 293A cells expressing
PNLIP or p.T221MPNLIP (P≤ 0.01) but the levels were not different be-
tween cells expressing the two recombinant lipases (Fig. 4B). Levels of
GRP94 were signiﬁcantly increased in cells transfected with p.T221M
PNLIP compared to the levels in control and PNLIP transfected cells
(P ≤ 0.01) (Fig. 4C). The GRP94 levels in cells expressing PNLIP did
not differ from the GRP94 levels in control cells.
Because BiP protein levels were elevated in cells transfected with
p.T221M PNLIP, we next determined if there was a downstream effectFig. 4. Effect of expression of p.T221M PNLIP in HEK 293A cells on ER stress. Cellular lysates of
three measurements from separate experiments were done in each case. (A) The relative amo
relative amounts of calreticulin determined by protein immunoblot and quantitated by den
quantitated by densitometry. (D) Total RNA was isolated from transfected HEK 293A cells. T
electrophoresis, ethidium bromide staining and densitometry. The upper panel is a representa
splicing quantitated by densitometry. **P ≤ 0.01.in the UPR. During ER stress, IRE1 is activated, which catalyzes the cyto-
plasmic splicing of XBP1 mRNA to generate a shorter XBP1 mRNA vari-
ant. This variant encodes a transcriptional activator critical for the UPR.
We performed RT-PCR analysis of XBP1 mRNA in mock, PNLIP and
p.T221M PNLIP transfected HEK 293A cells (Fig. 4D). Splicing of XBP1
mRNA was increased about 10-fold in cells transfected with p.T221M
PNLIP compared to the control cells (P ≤ 0.01). XBP1 mRNA splicing
was not increased in cells transfected with PNLIP.
We next assessed the levels of BiP and calreticulin mRNA and splic-
ing of XBP1mRNA in AR42J cells transducedwith adenovirus constructs
at various titers. In these cells there was a robust upregulation of BiP in
cells transduced with p.T221M PNLIP adenovirus compared to cells
transduced with control or PNLIP adenovirus (Fig. 5A). The increase in
BiP mRNA was about 18-fold above the levels in control cells at the
highest viral titer tested (P ≤ 0.01). In contrast to the ﬁndings in HEK
293A cells, there was an 11-fold upregulation of calreticulin mRNA in
the cells transduced with the highest titers of p.T221M PNLIP adenovi-
rus (P ≤ 0.05) (Fig. 5B). Like the HEK 293A cells, the expression of
p.T221MPNLIP in AR42J cells caused an increase in XBP1mRNA splicing
compared to the levels in cells expressing PNLIP (P ≤ 0.001) (Fig. 5C).
4. Discussion
4.1. Misfolding of p.T221M PNLIP
In this study, we determined the effect of the p.T221M PNLIP substi-
tution mutation on the function of PNLIP. The mutation was recently
identiﬁed in subjects with clinical PNLIP deﬁciency. On the basis oftransfected HEK 293A cells were prepared as described in Materials and methods. At least
unts of BiP determined by protein immunoblot and quantitated by densitometry. (B) The
sitometry. (C) The relative amounts of GRP94 determined by protein immunoblot and
he amount of XBP1 mRNA splicing was measured by RT-PCR, separation by agarose gel
tive agarose gel of the RT-PCR products. The bottom panel is the amount of XBP1 mRNA
Fig. 5. Effect of expression of p.T221MPNLIP in AR42J cells on ER stress. The cells were transducedwith three different titers of each adenovirus construct. Total RNAwas isolated from the
cells as described. The amount of mRNA encoding BiP and calreticulin was determined by real-time RT-PCR and the amount of XBP1mRNA splicing determined by RT-PCR, separation by
agarose gel electrophoresis, ethidiumbromide staining and densitometry. (A)Mean and SDof the relative BiP levels. (B)Mean and SDof the relative calreticulin levels. (C) Amount of XBP1
mRNA splicing is given. The upper panel shows a representative agarose gel separation of the RT-PCR products. The bottom panel presents the mean and SD of 3 experiments. *P≤ 0.05;
**P ≤ 0.01; ***P ≤ 0.001.
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matic activity of PNLIP by destabilizing the region around the active site
[12]. In addition, Thr221ﬂanks theβ9-loop,which contributes to an acyl
chain binding site [13,18]. Disruption of either structure could result in a
decrease or loss of activity and would explain the clinical phenotype of
PNLIP deﬁciency. Our results demonstrated absent lipase activity and a
marked secretion defect of p.T221MPNLIP expressed in two cell culture
models. The secretion defect is a result ofmisfolding and pathological ac-
cumulation of p.T221M PNLIP inside the cells. The presence of p.T221M
in an insoluble intracellular fraction suggests the misfolded mutant pro-
tein forms aggregates, most likely in the ER. This result could not be
accurately predicted. The reported analysis of protein stability using
the Eris server suggests the p.T221M change decreases stability of the
protein, but does not address effects on folding [12]. Folding RaCe
(http://www.iitm.ac.in/bioinfo/proteinfolding/Heading.html) predicted
that the substitution of Met for Thr221 resulted in a logarithmic increase
in the folding rate of 0.89/s, but this ﬁnding also does not address the ﬁ-
delity of folding [19]. Still, Thr221 is conserved in all known PNLIP and
PNLIPRP2 sequences and does not participate in the active site directly
or in acyl chain binding suggesting it is critical for maintaining structure.
By extrapolation, it is unlikely that pancreatic acinar cells secrete
p.T221M PNLIP to any signiﬁcant extent. A secretory defect would ex-
plain the steatorrhea reported in the two brothers carrying p.T221M
PNLIP in the homozygous state [12]. Unfortunately, lipase activity levels
in the pancreatic secretions of the brothers were not reported. The re-
port documented low serum lipase levels in the two brothers and this
ﬁnding in concert with steatorrhea was interpreted as evidence for a
functional defect in p.T221M PNLIP activity. The interpretation of the
low serum lipase levels is complicated. Although the method for mea-
suring lipase activity is not reported, they were likely done in a clinical
chemistry laboratory. The commercially available systems for measur-
ing serum lipase activity are not speciﬁc for PNLIP and the low activitymight be from other lipases such as carboxyl ester lipase or pancreatic
lipase related protein 2 (PNLIPRP2) rather than from low levels of
p.T221M PNLIP or normal protein levels of p.T221M PNLIP with low
speciﬁc activity.
4.2. Comparison of PNLIP deﬁciency in humans and mice
The clinical course of the two brothers resembles that reported for
other patients with probable PNLIP deﬁciency [1–10]. Themajor clinical
symptom was greasy, voluminous stools. Poor growth was not present
in the brothers or in the previously described patients. In fact, the
brothers' compliance with pancreatic enzyme replacement therapy
suffered because they were willing to cope with large, greasy stools
after meals in exchange for an “inability to gain weight despite very
high caloric intake [12].” That is, the brothers were resistant to develop-
ing obesity. The inability to gain weight differentiated the two brothers
from their unaffected family members.
Preserved weight gain and resistance to obesity is mimicked in
PNLIP-deﬁcient mice [20,21]. Early in life, PNLIP-deﬁcient mice gain
weight normally [21]. But, when placed on a high-fat, high-cholesterol
diet and followed over a longer time, the PNLIP-deﬁcientmice are resis-
tant to the obesity that develops in wild-type mice [12]. The PNLIP-
deﬁcient mice weigh less and have less fat body mass than the wild-
type mice fed the same diet.
The presence of signiﬁcant steatorrhea in the humans with PNLIP
deﬁciency differs from the phenotype of PNLIP-deﬁcient mice. The
mice have minimal to no steatorrhea depending on the method used
to measure fat absorption [20,21]. The explanation for this difference
is unclear and is further confounded by results in colipase-deﬁcient
mice. Adult colipase-deﬁcient mice have signiﬁcant steatorrhea on a
high-fat, high cholesterol diet [22]. Since mouse PNLIP is dependent
on colipase for activity in the presence of micellar concentrations of
1378 A. Szabó et al. / Biochimica et Biophysica Acta 1852 (2015) 1372–1379bile salts and PNLIP is the predominant colipase-dependent lipase
secreted by the pancreas, the effect of colipase deﬁciencywas attributed
to deﬁcient PNLIP activity [23–25].
4.3. The role of PNLIPRP2 and CEL in compensating for PNLIP deﬁciency in
humans and mice
The combination of steatorrhea in colipase-deﬁcient mice but not in
PNLIP-deﬁcientmice suggests other lipases contribute to fat digestion in
adultmice. To this point, mice deﬁcient in both PNLIP and carboxyl ester
lipase had steatorrhea although they still absorbed about 60% of the fat
in the high-fat, high-cholesterol diet [20]. The authors suggested that
PNLIPRP2 might account for some of the remaining fat digestion.
PNLIPRP2 activity is stimulated by colipase and it accounts for all of
the colipase-dependent lipase activity in the pancreas of a newborn
mouse, an age when PNLIP is not expressed [23,26]. It is plausible that
carboxyl ester lipase and PNLIPRP2 compensate for the loss of PNLIP
in the PNLIP-deﬁcient mice.
In the case of these brothers, it appears that PNLIPRP2 and CEL can-
not compensate for the loss of PNLIP and the result is steatorrhea. The
reason for this may lay in themarked differences in enzyme kinetics be-
tween themouse and human PNLIPRP2 lipases [23,27]. In particular the
speciﬁc activity of mouse PNLIPRP2 against long-chain triglycerides, the
major dietary fat, is about 7-fold greater than the activity of human
PNLIPRP2 even under optimal conditions [23,28]. In fact, the speciﬁc ac-
tivity ofmouse PNLIPRP2 against long chain triglycerides is only slightly
lower than the speciﬁc activity of mouse PNLIP. Furthermore, mouse
PNLIPRP2 has 10-fold higher speciﬁc activity against short and medium
chain triglycerides than human PNLIPRP2. The higher speciﬁc activity
may allow mouse PNLIPRP2 to adequately compensate for the absence
of PNLIP in PNLIP-deﬁcient mice.
4.4. ER stress response
The second important ﬁnding of our study is the up-regulation of the
ER stress response in cells expressing p.T221MPNLIP. A robust ER stress
response can activate cell-death pathways, which could potentially
damage the pancreas. This mechanism has been suggested for other
misfolding variants of PRSS1, CTRC and CPA1 [29–31]. Each of these var-
iants increases ER stress in transfected cells and are risk factors for
chronic pancreatitis in humans. The accumulation of misfolded
p.T221M PNLIP could also increase the risk for chronic pancreatitis. In
the report of the two brothers, there are suggestions that they had pan-
creatic insufﬁciency andnot just PNLIP deﬁciency. In addition to steator-
rhea, low serumcarnitine and low serumvitamin E levels, both brothers
had low fecal elastase levels and the proband had an abnormal
pancreolauryl test. Neither brother had evidence for an intestinalmuco-
sal defect thatmight impair fatty acid absorption. No radiographic imag-
ing of the pancreas was reported so it is not known if the brothers'
pancreas had anatomic abnormalities consistent with chronic pancrea-
titis. Even so, the available data suggests that the p.T221M PNLIP may
have broader affects not limited to fat digestion. Although the
p.T221MPNLIPmutation has only been reported in a single consanguin-
eous family, the possibility that other mutations in PNLIP increase the
risk for pancreatic disease should be considered.
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